Press Releases about Pfizer
Pfizer Presents Positive Data from Phase 2 Study of Ponsegromab in Patients with Cancer Cachexia
September 14, 2024
From Pfizer Inc.
Via Business Wire
Pfizer Highlights Diverse Oncology Portfolio and Combination Approaches at ESMO 2024
September 11, 2024
From Pfizer Inc.
Via Business Wire
Via Send2Press
Merck's Stock Dip Offers a Buying Opportunity: Here’s Why
August 20, 2024
Via MarketBeat
Topics
Intellectual Property
Exposures
Intellectual Property
From Pfizer Inc.
Via Business Wire
Phio Pharmaceuticals Announces New Chief Financial Officer
August 01, 2024
Via Newsfile
Topics
Initial Public Offering
Exposures
Securities Market
From Pfizer Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|